1. Departments of Radiation Oncology and
2. Institute of Biochemistry, University of Fribourg, CH-1700 Fribourg, Switzerland;
3. Dana Farber Cancer Research Institute, Boston, Massachusetts; and
4. Onyx Pharmaceuticals, Richmond, California;
5. University of Massachusetts, Worcester, Massachusetts
6. National Institutes of Health, Bethesda, Maryland;
7. Pharmacology and Toxicology, Medical College of Virginia, Richmond, Virginia 23298-0058;